The overall objectives of UMass CFAR Molecular Virology Core facility are: (1) to maintain and continuouslymonitor the safety operations of a BSL3- and a BSL2-containment facility that will support a safe andbiohazard-free environment for work with pathogenic primate immunodeficiency viruses; (2) to provideresources and services to participating CFAR investigators for their ongoing virus-related projects; and (3) tofunction as a central site where collaborations amongst UMass CFAR investigators is fostered. The Coreservices include: (1) assays for isolation, titration, phenotypic and genotypic characterization of virus; (2)providing a centralized source and repository for primary T-cells, macrophages & T-cell lines; and (3)molecular detection/diagnostic assays including qualitative and quantitative RNA and DNA-PCR for viralgenomes & state of the art, cutting edge LightCycler-based PCR assays for real-time detection andquantitation of HIV-1. The Molecular Virology Core facility, in conjunction with UMass CFAR-Clinical andMolecular Biology Core facilities, uphold the mission of UMass CFAR by providing standardized andcentralized routine research techniques and reagents; reducing expenditure by eliminating duplication ofeffort & by efficient use of personnel; and fostering new collaborative projects and grants. The MolecularVirology Core is also committed to provide educational & training opportunities to CFAR investigators andstudents/fellows in working within BSL3 containment facility, in developing new molecular virology assays, inBSL3 Certification, and in PCR Certification. Details of the Molecular Virology Core facility, its location, itsfunctions, the services provided are all available on the UMass CFAR Molecular Virology Core website(www.umassmed.edu/cfar/viroloavcore).

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI042845-10
Application #
7278941
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-07-15
Budget End
2008-06-30
Support Year
10
Fiscal Year
2007
Total Cost
$273,786
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Gonzalez-Perez, Maria Paz; Peters, Paul J; O'Connell, Olivia et al. (2017) Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol 91:
Ambade, Aditya; Satishchandran, Abhishek; Szabo, Gyongyi (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation. Sci Rep 6:21340
Peters, Paul J; Gonzalez-Perez, Maria Paz; Musich, Thomas et al. (2015) Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. Retrovirology 12:48
Fouda, Genevieve G; Cunningham, Coleen K; McFarland, Elizabeth J et al. (2015) Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. J Infect Dis 211:508-17
Musich, Thomas; O'Connell, Olivia; Gonzalez-Perez, Maria Paz et al. (2015) HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12:25
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Brehm, Michael A; Wiles, Michael V; Greiner, Dale L et al. (2014) Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods 410:3-17
Luzuriaga, Katherine; Tabak, Barbara; Garber, Manuel et al. (2014) HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210:1529-38
Rich, Josiah D; DiClemente, Ralph; Levy, Judith et al. (2013) Correctional facilities as partners in reducing HIV disparities. J Acquir Immune Defic Syndr 63 Suppl 1:S49-53

Showing the most recent 10 out of 122 publications